Retatrutides Phase 2 monotherapy weight loss (~24.2% at 48 weeks) is numerically larger than cagrilintides (~10.8% at 26 weeks), but those come from different trials, durations, and doses, and cagrilintides strongest data are as the CagriSema combination
The most commonly reported side effects are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation
Mit einem Premium-Abo erhltst du jeden Monat 1 Guthaben, mit dem du dir einen beliebigen Titel aus unserem gesamten Katalog aussuchen kannst
There is also a sport-eligibility dimension clinicians are often unaware of
A role of the enzyme in modulating stress responses by controlling JNK activity was also proposed 56, 57